Literature DB >> 14966026

Hibernating myocardium: high or low risk?

J H McGowan.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14966026      PMCID： PMC1768128          DOI： 10.1136/heart.2003.021006

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  14 in total

Review 1.  Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods.

Authors:  James H McGowan; John G F Cleland
Journal:  Am Heart J       Date:  2003-09       Impact factor: 4.749

2.  Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization.

Authors:  N V Marinho; B E Keogh; D C Costa; A A Lammerstma; P J Ell; P G Camici
Journal:  Circulation       Date:  1996-02-15       Impact factor: 29.690

3.  B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea.

Authors:  Alex Harrison; L Katherine Morrison; Padma Krishnaswamy; Radmila Kazanegra; Paul Clopton; Quyen Dao; Patricia Hlavin; Alan S Maisel
Journal:  Ann Emerg Med       Date:  2002-02       Impact factor: 5.721

4.  Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction.

Authors:  A Pasquet; A Robert; A M D'Hondt; R Dion; J A Melin; J L Vanoverschelde
Journal:  Circulation       Date:  1999-07-13       Impact factor: 29.690

5.  Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function.

Authors:  U Qureshi; S F Nagueh; I Afridi; P Vaduganathan; A Blaustein; M S Verani; W L Winters; W A Zoghbi
Journal:  Circulation       Date:  1997-02-04       Impact factor: 29.690

6.  B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.

Authors:  Rudolf Berger; Martin Huelsman; Karin Strecker; Anja Bojic; Petra Moser; Brigitte Stanek; Richard Pacher
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

7.  B-type natriuretic peptide in cardiovascular disease.

Authors:  James A de Lemos; Darren K McGuire; Mark H Drazner
Journal:  Lancet       Date:  2003-07-26       Impact factor: 79.321

8.  Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction.

Authors:  G Gioia; E Milan; R Giubbini; N DePace; J Heo; A S Iskandrian
Journal:  J Nucl Cardiol       Date:  1996 Mar-Apr       Impact factor: 5.952

Review 9.  The heart failure revascularisation trial (HEART): rationale, design and methodology.

Authors:  J G F Cleland; N Freemantle; S G Ball; R S Bonser; P Camici; S Chattopadhyay; D Dutka; J Eastaugh; J Hampton; S Large; M S Norell; D J Pennell; J Pepper; S Sanda; R Senior; D Smith
Journal:  Eur J Heart Fail       Date:  2003-06       Impact factor: 15.534

10.  Radioimmunometric assay of natriuretic peptide type-B (BNP) in heart failure.

Authors:  I Hervas; J Osca; J L Perez-Pastor; A Quesada; M A Arnau; J F Marti; L Almenar; P Bello; A Mateo
Journal:  Nucl Med Commun       Date:  2003-01       Impact factor: 1.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.